Global X S&P Biotech ETF is a sector & thematic ETF from Global X — 157 holdings, with $39.6m under management. 78% of its money is in health care. Its two largest holdings, MODERNA INC and TWIST BIOSCIENCE, make up 4% of the fund. It charges 0.45% a year.
Compare CURE with another fund →ACAD
ACADIA PHARMACEUTICALS
Health Care · United States · 0.68% of CURE on average
Contributed −$22 per $10k to CURE over the last month.
Loading…
Explained moves, and what each did to CURE
About CURE
- TypeSector & thematic
- IssuerGlobal X
- Size$39.6m
- Cost0.45% a year
- Holdings157
- Top sectorHealth Care 78%
- Top 2 holdings4%
CURE fell 0.5% over the last month. On $10,000, that's −$48. QURE was the biggest drag at −$45; MRNA helped most at +$119.
What moved it
Gain or loss per $10k invested
- MRNAModerna+$119
- IOVAIovance+$77
- GRALGrail+$70
- QUREUniqure−$45
- TWSTTwist+$38
- PRAXPraxis−$36
- TVTXTravere−$33
- ARWRArrowhead−$33
- INSMInsmed−$32
- NTRANatera+$31
- DNTHDianthus−$29
- IBRXImmunitybio+$28
- SRRKScholar Rock−$27
- PCVXVaxcyte+$24
- CELCCelcuity−$23
- ACADAcadia Pharma−$22
- BMRNBiomarin−$22
- ROIVRoivant−$21
- NKTRNektar−$19
- IMVTImmunovant−$18
- ORKAOruka−$18
- RXRXRecursion+$18
- CYTKCytokinetics−$18
- MDGLMadrigal−$17
- IONSIonis Pharma−$17
- UTHRUnited Thera.+$14
- INCYIncyte−$14
- ABBVAbbVie+$14
- AMGNAmgen+$12
- BIIBBiogen+$9
- EXELExelixis+$6
- CRSPCrispr−$6
- RVMDRevolution−$6
- HALOHalozyme+$6
- SYRESpyre−$6
- REGNRegeneron−$5
- GILDGilead+$5
- KRYSKrystal−$4
- VRTXVertex Pharma−$2
- TGTXTg Thera.−$1
- PTGXProtagonist+$0
- CurrencyForeign currencies against the Australian dollar+$234
- UnattributedHedging, fees, timing−$81
- CompoundingDaily returns multiply, they do not add−$34
- Fund return−$48
- Other 7 kinds of news−$4
- Other 5 kinds of news+$3
Each kind of news counts the days those moves happened; No flagged news is every other day. News is tracked for moves large enough to be flagged; most international holdings had none in this range.